▶ 調査レポート

世界のブプロピオンHCL市場 2028年:純度≥99%、純度≥99.5%

• 英文タイトル:Global Bupropion HCL Market Insights, Forecast to 2028

Global Bupropion HCL Market Insights, Forecast to 2028「世界のブプロピオンHCL市場 2028年:純度≥99%、純度≥99.5%」(市場規模、市場予測)調査レポートです。• レポートコード:QY2207C0681
• 出版社/出版日:QYResearch / 2022年7月15日
• レポート形態:英文、PDF、91ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のブプロピオンHCLの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にブプロピオンHCLの世界市場のxxx%を占める「純度≥99%」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「うつ病治療」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のブプロピオンHCLの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのブプロピオンHCL市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのブプロピオンHCL市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

ブプロピオンHCLのグローバル主要メーカーには、SUANFARMA、Dipharma、Aarti Industries Limited、Hikal、Cadila、OM Pharmaceutical、Supor Pharmaceuticals、Apeloa Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

ブプロピオンHCL市場は、種類と用途によって区分されます。世界のブプロピオンHCL市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度≥99%、純度≥99.5%

【用途別セグメント】
うつ病治療、禁煙治療、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- ブプロピオンHCL製品概要
- 種類別市場(純度≥99%、純度≥99.5%)
- 用途別市場(うつ病治療、禁煙治療、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のブプロピオンHCL販売量予測2017-2028
- 世界のブプロピオンHCL売上予測2017-2028
- ブプロピオンHCLの地域別販売量
- ブプロピオンHCLの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ブプロピオンHCL販売量
- 主要メーカー別ブプロピオンHCL売上
- 主要メーカー別ブプロピオンHCL価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(純度≥99%、純度≥99.5%)
- ブプロピオンHCLの種類別販売量
- ブプロピオンHCLの種類別売上
- ブプロピオンHCLの種類別価格
・用途別市場規模(うつ病治療、禁煙治療、その他)
- ブプロピオンHCLの用途別販売量
- ブプロピオンHCLの用途別売上
- ブプロピオンHCLの用途別価格
・北米市場
- 北米のブプロピオンHCL市場規模(種類別、用途別)
- 主要国別のブプロピオンHCL市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのブプロピオンHCL市場規模(種類別、用途別)
- 主要国別のブプロピオンHCL市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のブプロピオンHCL市場規模(種類別、用途別)
- 主要国別のブプロピオンHCL市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のブプロピオンHCL市場規模(種類別、用途別)
- 主要国別のブプロピオンHCL市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのブプロピオンHCL市場規模(種類別、用途別)
- 主要国別のブプロピオンHCL市場規模(トルコ、サウジアラビア)
・企業情報
SUANFARMA、Dipharma、Aarti Industries Limited、Hikal、Cadila、OM Pharmaceutical、Supor Pharmaceuticals、Apeloa Pharmaceutical
・産業チェーン及び販売チャネル分析
- ブプロピオンHCLの産業チェーン分析
- ブプロピオンHCLの原材料
- ブプロピオンHCLの生産プロセス
- ブプロピオンHCLの販売及びマーケティング
- ブプロピオンHCLの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ブプロピオンHCLの産業動向
- ブプロピオンHCLのマーケットドライバー
- ブプロピオンHCLの課題
- ブプロピオンHCLの阻害要因
・主な調査結果

Market Analysis and Insights: Global Bupropion HCL Market
Due to the COVID-19 pandemic, the global Bupropion HCL market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for % of the Bupropion HCL global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Depression Treatment segment is altered to an % CAGR throughout this forecast period.
China Bupropion HCL market size is valued at US$ million in 2021, while the US and Europe Bupropion HCL are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Bupropion HCL landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Bupropion HCL include SUANFARMA, Dipharma, Aarti Industries Limited, Hikal, Cadila, OM Pharmaceutical, Supor Pharmaceuticals and Apeloa Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Bupropion HCL capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Bupropion HCL by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Bupropion HCL Scope and Segment
Bupropion HCL market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Bupropion HCL market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥99%
Purity ≥99.5%
Segment by Application
Depression Treatment
Smoking Cessation Treatment
Other
By Company
SUANFARMA
Dipharma
Aarti Industries Limited
Hikal
Cadila
OM Pharmaceutical
Supor Pharmaceuticals
Apeloa Pharmaceutical
Production by Region
North America
Europe
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Bupropion HCL Product Introduction
1.2 Market by Type
1.2.1 Global Bupropion HCL Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥99%
1.2.3 Purity ≥99.5%
1.3 Market by Application
1.3.1 Global Bupropion HCL Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Depression Treatment
1.3.3 Smoking Cessation Treatment
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Bupropion HCL Production
2.1 Global Bupropion HCL Production Capacity (2017-2028)
2.2 Global Bupropion HCL Production by Region: 2017 VS 2021 VS 2028
2.3 Global Bupropion HCL Production by Region
2.3.1 Global Bupropion HCL Historic Production by Region (2017-2022)
2.3.2 Global Bupropion HCL Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 India
3 Global Bupropion HCL Sales in Volume & Value Estimates and Forecasts
3.1 Global Bupropion HCL Sales Estimates and Forecasts 2017-2028
3.2 Global Bupropion HCL Revenue Estimates and Forecasts 2017-2028
3.3 Global Bupropion HCL Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Bupropion HCL Sales by Region
3.4.1 Global Bupropion HCL Sales by Region (2017-2022)
3.4.2 Global Sales Bupropion HCL by Region (2023-2028)
3.5 Global Bupropion HCL Revenue by Region
3.5.1 Global Bupropion HCL Revenue by Region (2017-2022)
3.5.2 Global Bupropion HCL Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Bupropion HCL Production Capacity by Manufacturers
4.2 Global Bupropion HCL Sales by Manufacturers
4.2.1 Global Bupropion HCL Sales by Manufacturers (2017-2022)
4.2.2 Global Bupropion HCL Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Bupropion HCL in 2021
4.3 Global Bupropion HCL Revenue by Manufacturers
4.3.1 Global Bupropion HCL Revenue by Manufacturers (2017-2022)
4.3.2 Global Bupropion HCL Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Bupropion HCL Revenue in 2021
4.4 Global Bupropion HCL Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Bupropion HCL Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Bupropion HCL Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Bupropion HCL Sales by Type
5.1.1 Global Bupropion HCL Historical Sales by Type (2017-2022)
5.1.2 Global Bupropion HCL Forecasted Sales by Type (2023-2028)
5.1.3 Global Bupropion HCL Sales Market Share by Type (2017-2028)
5.2 Global Bupropion HCL Revenue by Type
5.2.1 Global Bupropion HCL Historical Revenue by Type (2017-2022)
5.2.2 Global Bupropion HCL Forecasted Revenue by Type (2023-2028)
5.2.3 Global Bupropion HCL Revenue Market Share by Type (2017-2028)
5.3 Global Bupropion HCL Price by Type
5.3.1 Global Bupropion HCL Price by Type (2017-2022)
5.3.2 Global Bupropion HCL Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Bupropion HCL Sales by Application
6.1.1 Global Bupropion HCL Historical Sales by Application (2017-2022)
6.1.2 Global Bupropion HCL Forecasted Sales by Application (2023-2028)
6.1.3 Global Bupropion HCL Sales Market Share by Application (2017-2028)
6.2 Global Bupropion HCL Revenue by Application
6.2.1 Global Bupropion HCL Historical Revenue by Application (2017-2022)
6.2.2 Global Bupropion HCL Forecasted Revenue by Application (2023-2028)
6.2.3 Global Bupropion HCL Revenue Market Share by Application (2017-2028)
6.3 Global Bupropion HCL Price by Application
6.3.1 Global Bupropion HCL Price by Application (2017-2022)
6.3.2 Global Bupropion HCL Price Forecast by Application (2023-2028)
7 North America
7.1 North America Bupropion HCL Market Size by Type
7.1.1 North America Bupropion HCL Sales by Type (2017-2028)
7.1.2 North America Bupropion HCL Revenue by Type (2017-2028)
7.2 North America Bupropion HCL Market Size by Application
7.2.1 North America Bupropion HCL Sales by Application (2017-2028)
7.2.2 North America Bupropion HCL Revenue by Application (2017-2028)
7.3 North America Bupropion HCL Sales by Country
7.3.1 North America Bupropion HCL Sales by Country (2017-2028)
7.3.2 North America Bupropion HCL Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Bupropion HCL Market Size by Type
8.1.1 Europe Bupropion HCL Sales by Type (2017-2028)
8.1.2 Europe Bupropion HCL Revenue by Type (2017-2028)
8.2 Europe Bupropion HCL Market Size by Application
8.2.1 Europe Bupropion HCL Sales by Application (2017-2028)
8.2.2 Europe Bupropion HCL Revenue by Application (2017-2028)
8.3 Europe Bupropion HCL Sales by Country
8.3.1 Europe Bupropion HCL Sales by Country (2017-2028)
8.3.2 Europe Bupropion HCL Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Bupropion HCL Market Size by Type
9.1.1 Asia Pacific Bupropion HCL Sales by Type (2017-2028)
9.1.2 Asia Pacific Bupropion HCL Revenue by Type (2017-2028)
9.2 Asia Pacific Bupropion HCL Market Size by Application
9.2.1 Asia Pacific Bupropion HCL Sales by Application (2017-2028)
9.2.2 Asia Pacific Bupropion HCL Revenue by Application (2017-2028)
9.3 Asia Pacific Bupropion HCL Sales by Region
9.3.1 Asia Pacific Bupropion HCL Sales by Region (2017-2028)
9.3.2 Asia Pacific Bupropion HCL Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Bupropion HCL Market Size by Type
10.1.1 Latin America Bupropion HCL Sales by Type (2017-2028)
10.1.2 Latin America Bupropion HCL Revenue by Type (2017-2028)
10.2 Latin America Bupropion HCL Market Size by Application
10.2.1 Latin America Bupropion HCL Sales by Application (2017-2028)
10.2.2 Latin America Bupropion HCL Revenue by Application (2017-2028)
10.3 Latin America Bupropion HCL Sales by Country
10.3.1 Latin America Bupropion HCL Sales by Country (2017-2028)
10.3.2 Latin America Bupropion HCL Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Bupropion HCL Market Size by Type
11.1.1 Middle East and Africa Bupropion HCL Sales by Type (2017-2028)
11.1.2 Middle East and Africa Bupropion HCL Revenue by Type (2017-2028)
11.2 Middle East and Africa Bupropion HCL Market Size by Application
11.2.1 Middle East and Africa Bupropion HCL Sales by Application (2017-2028)
11.2.2 Middle East and Africa Bupropion HCL Revenue by Application (2017-2028)
11.3 Middle East and Africa Bupropion HCL Sales by Country
11.3.1 Middle East and Africa Bupropion HCL Sales by Country (2017-2028)
11.3.2 Middle East and Africa Bupropion HCL Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 SUANFARMA
12.1.1 SUANFARMA Corporation Information
12.1.2 SUANFARMA Overview
12.1.3 SUANFARMA Bupropion HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 SUANFARMA Bupropion HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 SUANFARMA Recent Developments
12.2 Dipharma
12.2.1 Dipharma Corporation Information
12.2.2 Dipharma Overview
12.2.3 Dipharma Bupropion HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Dipharma Bupropion HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Dipharma Recent Developments
12.3 Aarti Industries Limited
12.3.1 Aarti Industries Limited Corporation Information
12.3.2 Aarti Industries Limited Overview
12.3.3 Aarti Industries Limited Bupropion HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Aarti Industries Limited Bupropion HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Aarti Industries Limited Recent Developments
12.4 Hikal
12.4.1 Hikal Corporation Information
12.4.2 Hikal Overview
12.4.3 Hikal Bupropion HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Hikal Bupropion HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Hikal Recent Developments
12.5 Cadila
12.5.1 Cadila Corporation Information
12.5.2 Cadila Overview
12.5.3 Cadila Bupropion HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Cadila Bupropion HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Cadila Recent Developments
12.6 OM Pharmaceutical
12.6.1 OM Pharmaceutical Corporation Information
12.6.2 OM Pharmaceutical Overview
12.6.3 OM Pharmaceutical Bupropion HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 OM Pharmaceutical Bupropion HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 OM Pharmaceutical Recent Developments
12.7 Supor Pharmaceuticals
12.7.1 Supor Pharmaceuticals Corporation Information
12.7.2 Supor Pharmaceuticals Overview
12.7.3 Supor Pharmaceuticals Bupropion HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Supor Pharmaceuticals Bupropion HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Supor Pharmaceuticals Recent Developments
12.8 Apeloa Pharmaceutical
12.8.1 Apeloa Pharmaceutical Corporation Information
12.8.2 Apeloa Pharmaceutical Overview
12.8.3 Apeloa Pharmaceutical Bupropion HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Apeloa Pharmaceutical Bupropion HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Apeloa Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Bupropion HCL Industry Chain Analysis
13.2 Bupropion HCL Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Bupropion HCL Production Mode & Process
13.4 Bupropion HCL Sales and Marketing
13.4.1 Bupropion HCL Sales Channels
13.4.2 Bupropion HCL Distributors
13.5 Bupropion HCL Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Bupropion HCL Industry Trends
14.2 Bupropion HCL Market Drivers
14.3 Bupropion HCL Market Challenges
14.4 Bupropion HCL Market Restraints
15 Key Finding in The Global Bupropion HCL Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer